已收盘 05-15 16:00:00 美东时间
-0.090
-1.12%
Sunrise Realty Trust (NASDAQ:SUNS) released first-quarter financial results and...
05-14 22:48
Sunrise Realty Trust (NASDAQ:SUNS) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.26 by 34.62 percent. This is a 12.9 percent increase over earnings of $0.31 per share from
05-14 19:52
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
今日重点评级关注:花旗:维持Candel Therapeutics"买入"评级,目标价从22美元升至26美元;Chardan Capital:维持CervoMed"买入"评级,目标价从15美元升至21美元
03-19 14:31
Keefe, Bruyette & Woods analyst Jade Rahmani maintains Sunrise Realty Trust (NASDAQ:SUNS) with a Market Perform and lowers the price target from $9.5 to $8.75.
03-18 20:02
Sunrise Realty Trust (NASDAQ:SUNS) reported quarterly earnings of $0.27 per share which missed the analyst consensus estimate of $0.30 by 9.09 percent. This is a 10 percent decrease over earnings of $0.30 per share from
03-12 19:51
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
Sunrise Realty Trust, Inc. ("SUNS" or the "Company") (NASDAQ:SUNS), a lender on the Tannenbaum Capital Group ("TCG") Real Estate platform, today announced that it has originated, closed, and exited a $14.0 million
02-04 21:17
今日重点评级关注:HC Wainwright & Co.:维持奥麦罗制药"买入"评级,目标价从20美元升至40美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从26美元升至27美元
01-09 20:22
Keefe, Bruyette & Woods analyst Jade Rahmani downgrades Sunrise Realty Trust (NASDAQ:SUNS) from Outperform to Market Perform and lowers the price target from $10.75 to $9.5.
01-09 00:12